Results 131 to 140 of about 35,561 (168)

Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations. [PDF]

Cancers (Basel)
Carturan A, Morè S, Poloni A, Rupoli S, Morsia E.   +4 more
europepmc   +1 more source

Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. [PDF]

Asian Pac J Cancer Prev
Soro SGC, Amalou G, Benchikh S, El Hamouchi A, Charoute H, Oukheda M, Abdelouaheb BB, Saile R, Lebrazi H, Nassereddine S.   +9 more
europepmc   +1 more source

Classification and Prognostic Stratification Based on Genomic Features in Myelodysplastic and Myeloproliferative Neoplasm- and Their Overlapping Conditions. [PDF]

Cancers (Basel)
Lee JM, Lee G, Kim T, Ahn A, Jung J, Kim YJ, Park S, Kwag D, Lee SE, Park SS, Kim TY, Cho B, Chung NG, Lee JW, Yoo JW, Jo S, Kim Y, Kim M.   +17 more
europepmc   +1 more source

Case Report of Hepatic Sinusoidal Obstruction Syndrome Complicated with Myeloproliferative Neoplasm and Focal Segmental Glomerulosclerosis. [PDF]

Case Rep Gastroenterol
Song Y, Zhen Y, Ma H, Feng B, Xie Y.
europepmc   +1 more source

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part Two - The team and patient care experiences. [PDF]

Can Oncol Nurs J
Cheung V, Powis M, Claudio JO, Lindberg G, Arruda A, Emanuele C, Nye T, Davidson MB, Bankar A, Sibai H, Gupta V, Maze D.   +11 more
europepmc   +1 more source

Elevated Vitamin B12 Levels in Myeloproliferative Neoplasm (MPN) Patients: A Potential Diagnostic and Prognostic Marker. [PDF]

J Blood Med
Fadul A, Abdalla E, Mohamed A, Ali B, Elamin N, Alsayed AA, Al-Mashdali AF, Singh K, Mohamed SF.   +8 more
europepmc   +1 more source

Correction to: ETV6::ABL1 fusion: from overlooked minor clone in myeloproliferative neoplasm to major player in leukemic transformation. [PDF]

Virchows Arch
Lee HW, Park MS, Kim B, Jung CW, Kim HJ, Kim HY.   +5 more
europepmc   +1 more source

Impact of the clinical nurse specialist role for the myeloproliferative neoplasm program: Part One - From timeliness of triage to cost-saving. [PDF]

Can Oncol Nurs J
Cheung V, Powis M, Claudio JO, Lindberg G, Arruda A, Emanuele C, Nye T, Davidson MB, Bankar A, Sibai H, Gupta V, Maze D.   +11 more
europepmc   +1 more source

Myeloproliferative neoplasm harboring both monosomy 7 and an ALK/ROS1 fusion gene: Proposal for a new disease entity. [PDF]

EJHaem
Yoshida H, Osone S, Konishi M, Tanaka S, Inaba T, Imamura T, Iehara T.   +6 more
europepmc   +1 more source

Uncommon Evolution From Acute Myeloid Leukaemia to <i>JAK2</i>-Mutated Myeloproliferative Neoplasm: Evidence of Clonal Persistence and Divergence From <i>TET2</i>/<i>SRSF2</i>-Mutated Haematopoietic Progenitors. [PDF]

EJHaem
Turingan MA, Hezaveh EB, Wei C, Cheung V, Maze D, Chang H.   +5 more
europepmc   +1 more source